|
Mölnlycke Health Care is a Swedish medical device company headquartered in Gothenburg and active internationally. The company manufactures and sells wound care and single-use surgical products and is a service provider to the healthcare sector. The surgical division includes medical devices such as drapes, gowns, facemasks, and headwear. 〔()〕 The wound care division includes medical device wound healing solutions such as dressings, compression products and skin care products and emollients.〔()〕 Featured products in wound care include those with Safetac® technology available exclusively on Mepitel® , Mepilex® , and other dressings. The wound care product assortment also includes WoundEL® electrostimulation for hard-to-heal wounds, wound dressings such as Mepore® , compression bandages, dermatology products and retention products such as Tubifast®. 〔()〕 ==History, mergers and acquisitions== The company was founded in 1849 by Gustaf Ferdinand Hennig in Mölnlycke as a textile manufacturer.〔(Mölnlycke History )〕 In the 1940s Mölnlycke began supplying the health care industry with products, such as gauze. 1975 Mölnlycke AB was acquired by Svenska Cellulosa Aktiebolaget (SCA) (publ) where it made up their Clinical division.〔 At that time SCA was known as Bowater-Scott, and the new company, called Sancella Pty Limited, manufactured personal care products.〔(【引用サイトリンク】title=SCA in Australia )〕 1997 SCA sold the Clinical products division to Nordic Capital who merged it with Kolmi-Set acquired by Tamro〔(Nordic Capital Acquires Mölnlycke Clinical Products from SCA ) Nordic Capital press release, 29 October 1997〕 and named it Mölnlycke Health Care AB.〔 Mölnlycke Health Care started operations as an independent company in 1998.〔 2001, Mölnlycke Health Care acquired the single-use surgical BARRIER product line from Johnson & Johnson.〔(Mölnlycke Health Care acquires BARRIER from Johnson & Johnson )〕 2005 Mölnlycke Health Care AB was acquired from Nordic Capital by Apax Partners in June 2005 and subsequently merged with Medlock Medical and Regent Medical. The merged company became Mölnlycke Health Care Group.〔(Apax Partners Acquires Mölnlycke Health Care from Nordic Capital ) Apax Partners press release, 26 January 2007〕 2007 Apax Partners sold Mölnlycke Health Care Group to Investor AB and Morgan Stanley in January 2007.〔(Investor AB and Morgan Stanley Principal Investments Acquires Mölnlycke Health Care Group from Apax Partners ) Investor AB press release, 26 January 2007〕 2008 Mölnlycke Health Care acquired Pharmaset in October 2008, a French manufacturer of surgical single-use kits.〔(Mölnlycke Health Care Acquires Pharmaset ) Mölnlycke Health Care press release, 16 January 2009〕 2009 The company acquired JKT, a Polish manufacturer of surgical disposable products.〔(Mölnlycke Health Care Acquires JKT ) Mölnlycke Health Care press release, 3 June 2009〕 2010 The company acquired Rynel, Inc. in January 2010, an American manufacturer of hydrophilic polyurethane foam.〔(Mölnlycke Health Care Acquires Rynel ) Mölnlycke Health Care press release, 15 February 2010〕 * Investor AB acquired Morgan Stanley Principal Investments' stake in Mölnlycke Health Care in August 2010.〔(Investor Acquires Shares in Mölnlycke Health Care ) Investor press release, 26 August 2010〕 The acquisition made Investor AB a 96% owner in the company. The remaining 4% is owned by management.〔(Investor takes over Mölnlycke ) Dagens Industri article, 26 August 2010〕 The company is in a rapid growth from 2000 based on the competitive health care products and good management team. 2011 The company launched the construction of a new manufacturing facility at Brunswick Landing in June 2011, site of the former Naval Air Station Brunswick, in Brunswick, Maine, United States, representing a significant milestone for the company to become a leading health-care product manufacture in the world. The factory will produce health care products for U.S market from 2012, and significantly reduce the manufacturing cost and assist new product development. * 2011, the company is ranked the 2nd largest advanced wound dressing company in the world and still keeps growing. 2012 The company acquires Brennen Medical. * The company acquires WoundEL® from Gerromed GmbH. * Mölnlycke Health Care establishes the subsidiary Mölnlycke Health Care Scotland Ltd. 2013 The company signed a licence agreement with Covalon Technologies. 2014 The company announced its expansion plans for its Wiscasset, Maine manufacturing facility in January 2014.〔(【引用サイトリンク】title=Mölnlycke Health Care expands Wiscasset manufacturing site )〕 抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』 ■ウィキペディアで「Mölnlycke Health Care」の詳細全文を読む スポンサード リンク
|